Multiple sclerosis: Advances in understanding, diagnosing, and treating the underlying disease

被引：42

作者：

Fox, RJ

Bethoux, F

Goldman, MD

Cohen, JA

机构：

[1] Cleveland Clin Fdn, Mellen Ctr Multiple Sclerosis Treatment & Res, Dept Neurol, Cleveland, OH 44195 USA

[2] Case Western Reserve Univ, Cleveland Clin, Lerner Sch Med, Cleveland, OH 44106 USA

来源：

CLEVELAND CLINIC JOURNAL OF MEDICINE | 2006年 / 73卷 / 01期

关键词：

D O I：

10.3949/ccjm.73.1.91

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent advances in our understanding of the diagnosis, imaging, pathology, and clinical monitoring of multiple sclerosis (MS) have significantly increased our ability to successfully treat this often perplexing neurologic disorder. Magnetic resonance imaging (MRI) is now integral to the diagnostic process. Treatment of MS can be considered as three parallel pathways: treatment of relapses, symptom management, and long-term prevention of tissue injury.

引用

页码：91 / 102

页数：12

共 49 条

[1] Fatigue in multiple sclerosis: Cross-sectional correlation with brain MRI findings in 71 patients [J].

Bakshi, R ;

Miletich, RS ;

Henschel, K ;

Shaikh, ZA ;

Janardhan, V ;

Wasay, M ;

Stengel, LM ;

Ekes, R ;

Kinkel, PR .

NEUROLOGY, 1999, 53 (05) :1151-1153

[2] DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED, CROSSOVER TRIAL OF HIGH-DOSE METHYLPREDNISOLONE IN PATIENTS WITH CHRONIC PROGRESSIVE FORM OF MULTIPLE-SCLEROSIS [J].

CAZZATO, G ;

MESIANO, T ;

ANTONELLO, R ;

MONTI, F ;

CARRARO, N ;

TORRE, P ;

BOSCO, A ;

CARGNELUTTI, D .

EUROPEAN NEUROLOGY, 1995, 35 (04) :193-198

[3] Benefit of interferon β-1a on MSFC progression in secondary progressive MS [J].

Cohen, JA ;

Cutter, GR ;

Fischer, JS ;

Goodman, AD ;

Heidenreich, FR ;

Kooijmans, MF ;

Sandrock, AW ;

Rudick, RA ;

Simon, JH ;

Simonian, NA ;

Tsao, EC ;

Whitaker, JN .

NEUROLOGY, 2002, 59 (05) :679-687

[4]

Comi G, 2000, NEUROLOGY, V54, pA85

[5] An open label study of the effects of rituximab in neuromyelitis optica [J].

Cree, BAC ;

Lamb, S ;

Morgan, K ;

Chen, A ;

Waubant, E ;

Genain, C .

NEUROLOGY, 2005, 64 (07) :1270-1272

[6] Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype [J].

Dhib-Jalbut, S ;

Chen, M ;

Said, A ;

Zhan, M ;

Johnson, KP ;

Martin, R .

JOURNAL OF NEUROIMMUNOLOGY, 2003, 140 (1-2) :163-171

[7]

DUQUETTE P, 1995, NEUROLOGY, V45, P1277

[8] Randomised double-blind placebo-controlled study of interferon β-1a in relapsing/remitting multiple sclerosis [J].

Ebers, GC ;

Rice, G ;

Lesaux, J ;

Paty, D ;

Oger, J ;

Li, DKB ;

Beall, S ;

Devonshire, V ;

Hashimoto, S ;

Hooge, J ;

Kastrukoff, L ;

Krieger, C ;

Mezei, M ;

Seland, P ;

Vorobeychi, G ;

Morrison, W ;

Nelson, J ;

Freedman, MS ;

Chrisie, S ;

Nelson, R ;

Rabinovitch, H ;

Freedman, C ;

Hartung, HP ;

Rieckmann, P ;

Archelos, J ;

Jung, S ;

Weilbach, F ;

Flachenecke, P ;

Sauer, J ;

Hommes, O ;

Jongen, P ;

Brouwer, S ;

McLeod, J ;

Pollard, J ;

Ng, R ;

Sandberg-Wollheim, M ;

Källén, K ;

Nilsson, P ;

Ekberg, R ;

Lundgren, A ;

Jadbäck, G ;

Wikström, J ;

Multanen, J ;

Valjakka, M ;

Carton, H ;

Lissoir, F ;

Declerq, I ;

Vieren, M ;

Peeters, E ;

Dubois, B .

LANCET, 1998, 352 (9139) :1498-1504

[9] New directions in MS therapeutics: vehicles of hope [J].

Fox, RJ ;

Ransohoff, RM .

TRENDS IN IMMUNOLOGY, 2004, 25 (12) :632-636

[10] Mycophenolate mofetil in multiple sclerosis [J].

Frohman, EM ;

Brannon, K ;

Racke, MK ;

Hawker, K .

CLINICAL NEUROPHARMACOLOGY, 2004, 27 (02) :80-83

← 1 2 3 4 5 →